Prev Close | 182.82 |
Day Low/High | 179.58 / 185.48 |
52 Wk Low/High | 112.60 / 187.67 |
Prev Close | 182.82 |
Day Low/High | 179.58 / 185.48 |
52 Wk Low/High | 112.60 / 187.67 |
Exchange | NYSE |
Shares Outstanding | 160.56B |
Market Cap | 29.35B |
P/E Ratio | 14.25 |
Div & Yield | N.A. (N.A) |
I've been pleasantly surprised by my conversations with folks at my recent book signings.
TheStreet's Jim Cramer breaks down Ford earnings, Akamai's loss and McKesson's bid to buy Celesio.
Restaurant weakness means more people are cooking at home says Real Money Pro Contributor Chis Versace. Here's how to trade the group.
Ebix Trix, McKesson Moolah, Comfortably Dumb and Dim & Zimmer highlight Gregg Greenberg's list of the dumbest things on Wall Street last week.
Here is my compilation of last night's profit reports. 24 beats: W&T Offshore (WTI) Oasis Petroleum (OAS) Marathon Oil (MRO) Huntington Ingalls Industries (HII) Cognizant Technology Solutions (CTSH) Disney (DIS) Electronic Arts (EA) Regency Centers ...
Express Scripts and McKesson could both see weakness.
That's the question of the day as the indices hit all-time highs and analysts raise their S&P estimates.
These days, a good balance sheet and nice earnings are enough to shoot a stock into the stratosphere.
Now we get to the trades themselves.
Dunkin' Brands and McKesson look poised to move higher.
Unless the company raises the dividend, further upside potential for this food company is probably limited.
These competing drug distributors are on diverging paths.
Proceed with caution out of the starting blocks.
U.S. futures are pointing lower despite some big deals in the offing.
Several factors got me thinking about health care today, and this company in particular.